PRDM16/MEL1: A novel Smad binding protein expressed in murine embryonic orofacial tissue

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1773, Issue 6, 2007, Pages 814-820

  Warner, Dennis R ^a   Horn, Kristin H ^a   Mudd, Lisa ^a   Webb, Cynthia L ^a   Greene, Robert M ^a   Pisano, M Michele ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

MEL1; Orofacial; PRDM16; Smad; TGF

Indexed keywords

PROTEIN MEL1; PROTEIN PRDM16; SMAD PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; FACE; FEMALE; IN SITU HYBRIDIZATION; MALE; MOUSE; MOUTH; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TWO HYBRID SYSTEM;

ANIMALS; DNA-BINDING PROTEINS; MICE; MICE, INBRED ICR; MOUTH; ORGAN SPECIFICITY; ORGANOGENESIS; PROTEIN BINDING; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

MURINAE;

EID: 34249676875     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2007.03.016     Document Type: Article

References (40)

1. Ito Y., Yeo J.Y., Chytil A., Han J., Bringas P.J., Nakajima A., Shuler C.F., Moses H.L., and Chai Y. Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects. Development 130 (2003) 5269-5280
2. Pisano M.M., Mukhopadhyay P., and Greene R.M. Molecular fingerprinting of TGFbeta-treated embryonic maxillary mesenchymal cells. Orthod. Craniofac. Res. 6 (2003) 194-209
3. D'Angelo M., Chen J.M., Ugen K., and Greene R.M. TGF beta 1 regulation of collagen metabolism by embryonic palate mesenchymal cells. J. Exp. Zool. 270 (1994) 189-201
4. D'Angelo M., and Greene R.M. Transforming growth factor-beta modulation of glycosaminoglycan production by mesenchymal cells of the developing murine secondary palate. Dev. Biol. 145 (1991) 374-378
5. Xiao Z., Liu X., Henis Y.I., and Lodish H.F. A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 7853-7858
6. Pouponnot C., Jayaraman L., and Massague J. Physical and functional interaction of SMADs and p300/CBP. J. Biol. Chem. 273 (1998) 22865-22868
7. Weisberg E., Winnier G.E., Chen X., Farnsworth C.L., Hogan B.L., and Whitman M. A mouse homologue of FAST-1 transduces TGF beta superfamily signals and is expressed during early embryogenesis. Mech. Dev. 79 (1998) 17-27
8. vonMikecz A., Zhang S., Montminy M., Tan E.M., and Hemmerich P. CREB-binding protein (CBP)/p300 and RNA polymerase II colocalize in transcriptionally active domains in the nucleus. J. Cell Biol. 150 (2000) 265-273
9. Ait-Si-Ali S., Ramirez S., Barre F.X., Dkhissi F., Magnaghi-Jaulin L., Girault J.A., Robin P., Knibiehler M., Pritchard L.L., Ducommun B., Trouche D., and Harel-Bellan A. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature 396 (1998) 184-186
10. Dennler S., Huet S., and Gauthier J.M. A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3. Oncogene 18 (1999) 1643-1648
11. Proetzel G., Pawlowski S.A., Wiles M.V., Yin M., Boivin G.P., Howles P.N., Ding J., Ferguson M.W., and Doetschman T. Transforming growth factor-β 3 is required for secondary palate fusion. Nat. Genet. 11 (1995) 409-414
12. Warner D.R., Pisano M.M., Roberts E.A., and Greene R.M. Identification of three novel Smad binding proteins involved in cell polarity. FEBS Lett. 539 (2003) 167-173
13. Warner D.R., Roberts E.A., Greene R.M., and Pisano M.M. Identification of novel Smad binding proteins. Biochem. Biophys. Res. Commun. 312 (2003) 1185-1190
14. Warner D.R., Bhattacherjee V., Yin X., Singh S., Mukhopadhyay P., Pisano M.M., and Greene R.M. Functional interaction between Smad, CREB binding protein, and p68 RNA helicase. Biochem. Biophys. Res. Comm. 324 (2004) 70-76
15. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
16. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., S.J.A., and Struhl K. Current Protocols in Molecular Biology (1994), John Wiley and Sons Inc., New York
17. Warner D.R., Greene R.M., and Pisano M.M. Cross-talk between the TGFbeta and Wnt signaling pathways in murine embryonic maxillary mesenchymal cells. FEBS Lett. 579 (2005) 3539-3546
18. Heid C.A., Stevens J., Livak K.J., and Williams P.M. Real time quantitative PCR. Genome Res. 6 (1996) 986-994
19. Ellis L.R., Warner D.R., Greene R.M., and Pisano M.M. Interaction of Smads with collagen types I, III, and V. Biochem. Biophys. Res. Commun. 310 (2003) 1117-1123
20. Mochizuki N., Shimizu S., Nagasawa T., Tanaka H., Taniwaki M., Yokota J., and Morishita K. A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells. Blood 96 (2000) 3209-3214
21. D'Angelo M., Chen J.-M., Ugen K., and Greene R. TGFβ1 regulation of collagen metabolism by embryonic palate mesenchymal cells. J. Exp. Zool. 270 (1994) 189-201
22. Nakao A., Afrakhte M., Moren A., Nakayama T., Christian J.L., Heuchel R., Itoh S., Kawabata M., Heldin C.H., and ten Dijke P. Identification of Smad7, a TGF-beta-inducible antagonist of TGF-beta signalling. Nature 389 (1997) 631-635
23. Mochizuki N., Shimizu S., Nagasawa T., Tanaka H., Taniwaki M., Yokota J., and Morishita K. A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells. Blood 96 (2000) 3209-3214
24. Yoshida M., Nosaka K., Yasunaga J., Nishikata I., Morishita K., and Matsuoka M. Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells. Blood 103 (2004) 2753-2760
25. Keller A.D., and Maniatis T. Identification and characterization of a novel repressor of beta-interferon gene expression. Genes Dev. 5 (1991) 868-879
26. Barjesteh van Waalwijk van Doorn-Khosrovani S., Erpelinck C., Lowenberg B., and Delwel R. Low expression of MDS1-EVI1-like-1 (MEL1) and EVI1-like-1 (EL1) genes in favorable-risk acute myeloid leukemia. Exp. Hematol. 31 (2003) 1066-1072
27. Nishikata I., Sasaki H., Iga M., Tateno Y., Imayoshi S., Asou N., Nakamura T., and Morishita K. A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation. Blood 102 (2003) 3323-3332
28. Alliston T., Ko T.C., Cao Y., Liang Y.Y., Feng X.H., Chang C., and Derynck R. Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1. J. Biol. Chem. 280 (2005) 24227-24237
29. Sood R., Talwar-Trikha A., Chakrabarti S.R., and Nucifora G. MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1. Leukemia 13 (1999) 348-357
30. Izutsu K., Kurokawa M., Imai Y., Maki K., Mitani K., and Hirai H. The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling. Blood 97 (2001) 2815-2822
31. Yu L., Gu S., Alappat S., Song Y., Yan M., Zhang X., Zhang G., Jiang Y., Zhang Z., Zhang Y., and Chen Y. Shox2-deficient mice exhibit a rare type of incomplete clefting of the secondary palate. Development 132 (2005) 4397-4406
32. Jin J.Z., and Ding J. Analysis of Meox-2 mutant mice reveals a novel postfusion-based cleft palate. Dev. Dyn. 235 (2006) 539-546
33. Zhang Z., Song Y., Zhao X., Zhang X., Fermin C., and Chen Y. Rescue of cleft palate in Msx1-deficient mice by transgenic Bmp4 reveals a network of BMP and Shh signaling in the regulation of mammalian palatogenesis. Development 129 (2002) 4135-4146
34. Buass F.W. Mouse genomics gets the royal treatment. GenomeBiology 5 (2004) 310
35. Bjork B.C., Vieira A.R., Faust S., Camper S.A., Murray J.C., and Beier D.R. Phenotypic, Genetic, and Developmental Characterization of CPO1, a Recessive ENU-induced Mouse Model of Cleft Palate (2006), Mouse Molecular Genetics Cold Spring Harbor Press, Woodbury, NY 27
36. Van Campenhout C., Nichane M., Antoniou A., Pendeville H., Bronchain O.J., Marine J.C., Mazabraud A., Voz M.L., and Bellefroid E.J. Evi1 is specifically expressed in the distal tubule and duct of the Xenopus pronephros and plays a role in its formation. Dev. Biol. 294 (2006) 203-219
37. Lan Y., Ovitt C.E., Cho E.S., Maltby K.M., Wang Q., and Jiang R. Odd-skipped related 2 (Osr2) encodes a key intrinsic regulator of secondary palate growth and morphogenesis. Development 131 (2004) 3207-3216
38. Dudas M., Nagy A., Laping N.J., Moustakas A., and Kaartinen V. TGFβ-3-induced palatal fusion is mediated by Alk-5/Smad pathway. Dev. Biol. 266 (2004) 96-108
39. Dudas M., Kim J., Li W.Y., Nagy A., Larsson J., Karlsson S., Chai Y., and Kaartinen V. Epithelial and ectomesenchymal role of the type I TGF-beta receptor ALK5 during facial morphogenesis and palatal fusion. Dev. Biol. 296 (2006) 298-314
40. Liu W., Sun X., Braut A., Mishina Y., Behringer R.R., Mina M., and Martin J.F. Distinct functions for Bmp signaling in lip and palate fusion in mice. Development 132 (2005) 1453-1461